Anna Moretti

Milan, 20153, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.

Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.

Journal: International journal of molecular sciences

Published: February 01, 2023

Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.

Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.

Journal: Breast cancer research : BCR

Published: February 02, 2022

Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).

Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 23, 2020

Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.

Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.

Journal: Clinical breast cancer

Published: April 05, 2020

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.

Journal: PloS one

Published: March 04, 2019

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.

Journal: Scientific reports

Published: January 16, 2018

The prognostic role of tumor size in early breast cancer in the era of molecular biology.

The prognostic role of tumor size in early breast cancer in the era of molecular biology.

Journal: PloS one

Published: July 05, 2017

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.

Journal: Clinical breast cancer

Published: May 15, 2017

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities.

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities.

Journal: PloS one

Published: February 24, 2016

A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project.

A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project.

Journal: Tumori

Published: July 16, 2015

Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers.

Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers.

Journal: Tumori

Published: December 24, 2013

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

Journal: Future oncology (London, England)

Published: December 04, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026